Andere Sprachen Melodiol Global Health Limited

Aktien

A3EML9

AU0000282840

ME1

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:47 30.04.2024			% 5 Tage	% 1. Jan.
0,004 ^AUD	+33,33 %		-20,00 %	-90,00 %

29.02.	Melodiol Global Health Limited meldet die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Melodiol Global Health Limited gibt den Rücktritt von Erlyn Dawson als Joint Company Secretary bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Melodiol Global's Revenue Surges 79% in Q1	16.04.
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	09.04.
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million	26.03.
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces	13.02.
Melodial's Unit Logs AU$1 Million Revenues in January	07.02.
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary	21.12.
Melodiol Global Health Limited Reports Unaudited Revenue Results for the Nine Months of 2023	13.11.
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October	02.11.
Melodiol Global Health Achieves 80% Remission Rate from Phase Two Hallucinogenic Trial	12.10.23
Melodial's Canadian Arm Mernova Logs Record Sales in Q3	10.10.23
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31.08.23
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	02.08.23
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders	20.07.23
Melodiol Global Health Limited Announces Revenue Results for Third Quarter of 2023	19.07.23
Melodiol Global Health Triples Q2 Net Sales	13.07.23
Creso Pharma Changes Name to Melodiol Global Health	13.06.23
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia	09.06.23
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe	05.06.23
Creso Pharma Raises AU$2.5 Million Via Share Issue	19.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Melodiol Global Health Limited

Aktien

A3EML9

AU0000282840

ME1

Andere Sprachen

Filter